Influence of Renal Function and Age on the Pharmacokinetics of Levofloxacin in Patients with Bone and Joint Infections
Despite its efficacy and toxicity being exposure-related, levofloxacin pharmacokinetics in patients with bone and joint infections has been poorly described to date, so the possible need for a dose adjustment is unknown in this population. A prospective population pharmacokinetic study was conducted...
Saved in:
Main Authors: | Gauthier Eloy (Author), David Lebeaux (Author), Manon Launay (Author), Marie-Paule Fer (Author), Eliane Billaud (Author), Emmanuel Douez (Author), Jean-Luc Mainardi (Author), Benjamin Bouyer (Author), Vincent Jullien (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Personalized therapeutics for levofloxacin: a focus on pharmacokinetic concerns
by: Gao CH, et al.
Published: (2014) -
HPLC determination, pharmacokinetics and relative bioavailability of levofloxacin produced by «OZONE», Russia
by: S. N. Kondratenko, et al.
Published: (2013) -
Population Pharmacokinetics of Orally Administered Clindamycin to Treat Prosthetic Joint Infections: A Prospective Study
by: Léo Mimram, et al.
Published: (2022) -
Population Pharmacokinetics Modeling of Levofloxacin In Rabbit By Intravenous Bolus Injection and Peroral Administration
by: Akhmad Kharis Nugroho, et al.
Published: (2021) -
Levofloxacin-Associated Neurotoxicity in a Patient with a High Concentration of Levofloxacin in the Blood and Cerebrospinal Fluid
by: Masashi Nishikubo, et al.
Published: (2019)